At the same time, DCA analysis also showed the superiority of the model’s predictive capacity for predicting 1-year, 3-year, and 5-year survival of patients with TP53 wild-type HCC (Figure 5E). This evidence concerns the gene TP53 and hepatocellular carcinoma.